Entity Common Stock, Shares Outstanding of aTYR PHARMA INC from 10 Jun 2015 to 02 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
aTYR PHARMA INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Jun 2015 to 02 Mar 2026.
  • aTYR PHARMA INC Entity Common Stock, Shares Outstanding for the quarter ending 02 Mar 2026 was 98,051,212, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

aTYR PHARMA INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 98,051,212 +9,192,600 +10% 02 Mar 2026 10-K 05 Mar 2026 2025 FY
Q3 2025 97,986,634 +14,044,227 +17% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 97,986,634 +22,190,436 +29% 01 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 88,858,612 +21,108,588 +31% 07 Mar 2025 10-K 13 Mar 2025 2024 FY
Q3 2024 83,942,407 +25,382,346 +43% 05 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 75,796,198 +18,750,026 +33% 09 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 67,750,024 +14,587,972 +27% 08 Mar 2024 10-K 14 Mar 2024 2023 FY
Q3 2023 58,560,061 +29,550,679 +102% 03 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 57,046,172 +28,421,126 +99% 04 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 53,162,052 +25,366,258 +91% 10 Mar 2023 10-K 14 Mar 2023 2022 FY
Q3 2022 29,009,382 +1,218,705 +4.4% 08 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 28,625,046 +11,705,174 +69% 12 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 27,795,794 +11,784,409 +74% 10 Mar 2022 10-K 15 Mar 2022 2021 FY
Q3 2021 27,790,677 +17,666,650 +175% 09 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 16,919,872 +7,382,934 +77% 09 Aug 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 16,011,385 +6,658,887 +71% 19 Mar 2021 10-K 24 Mar 2021 2020 FY
Q3 2020 10,124,027 +6,233,842 +160% 06 Nov 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 9,536,938 +5,646,753 +145% 07 Aug 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 9,352,498 -25,414,635 -73% 19 Mar 2020 10-K 26 Mar 2020 2019 FY
Q3 2019 3,890,185 -26,133,358 -87% 08 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 3,890,185 -25,966,776 -87% 07 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 34,767,133 +4,969,470 +17% 15 Mar 2019 10-K 26 Mar 2019 2018 FY
Q3 2018 30,023,543 +265,196 +0.89% 08 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 29,856,961 +6,017,954 +25% 07 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 29,797,663 +6,049,567 +25% 15 Mar 2018 10-K 20 Mar 2018 2017 FY
Q3 2017 29,758,347 +6,039,818 +25% 07 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 23,839,007 +120,478 +0.51% 04 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 23,748,096 +70,793 +0.3% 08 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 23,718,529 +70,125 +0.3% 07 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 23,718,529 +83,998 +0.36% 05 Aug 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 23,677,303 24 Mar 2016 10-K 30 Mar 2016 2015 FY
Q3 2015 23,648,404 06 Nov 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 23,634,531 10 Jun 2015 10-Q 18 Jun 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.